0001601485-21-000072.txt : 20211116 0001601485-21-000072.hdr.sgml : 20211116 20211116160901 ACCESSION NUMBER: 0001601485-21-000072 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211115 FILED AS OF DATE: 20211116 DATE AS OF CHANGE: 20211116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rhodes Jennifer J CENTRAL INDEX KEY: 0001568249 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39990 FILM NUMBER: 211416135 MAIL ADDRESS: STREET 1: C/O ADAMAS PHARMACEUTICALS INC. STREET 2: 1900 POWELL ST., SUITE 750 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Angion Biomedica Corp. CENTRAL INDEX KEY: 0001601485 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113430072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 51 CHARLES LINDBERGH BOULEVARD CITY: UNIONDALE STATE: NY ZIP: 11553 BUSINESS PHONE: (415) 655-4899 MAIL ADDRESS: STREET 1: 51 CHARLES LINDBERGH BOULEVARD CITY: UNIONDALE STATE: NY ZIP: 11553 4 1 wf-form4_163709656126099.xml FORM 4 X0306 4 2021-11-15 0 0001601485 Angion Biomedica Corp. ANGN 0001568249 Rhodes Jennifer J C/O ANGION BIOMEDICA CORP. 51 CHARLES LINDBERGH BLVD. UNIONDALE NY 11553 0 1 0 0 See Remarks Common Stock 2021-11-15 4 S 0 433 4.40 D 30850 D The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") granted by the Issuer. Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary /s/ Jennifer J. Rhodes 2021-11-16